In the News

A recent Memorial Sloan Kettering study shows that some circulating tumor cells can circle back and infiltrate their tumor of origin, enhancing its growth and aggressiveness.

Diagnosed with ovarian cancer at 51, Pauline Larkin feared her racing days were over — within the year, she was running in the NYC marathon with her MSK doctors by her side.

New MSK research discovered ferroptosis regulators that suggest therapeutic opportunities against hormone receptor-positive cancers; examined how tumor-associated macrophages might be turned against cancer; acquired new insights into joint inflammation in rheumatoid arthritis; developed a systems-level platform called epichaperomics to map changes in interactors among thousands of proteins involved in cancer-related processes; and investigated how artificial intelligence could help diagnose an invasive form of breast cancer.

Nikki Chotas, who uses the pronouns they/them, has dedicated much of their life to speaking up for and working to empower those who may feel helpless and without a voice. They attribute their pursuits in part to feeling voiceless in their younger years.

Learn how an MSK laboratory is bringing much-needed focus to cancer-related lymphedema and investigating new ways to prevent the complication.

Researchers have found that more than 20% of people with a type of cancer called advanced non-clear cell renal cell carcinoma have disease that is driven by inherited cancer mutations.

Find tools for discussing a cancer diagnosis with your children.

Discover some of the most exciting research that Memorial Sloan Kettering scientists are pursuing in the fight against cancer.

Joan Massagué, Chair of the Cancer Biology and Genetics Program in the Sloan Kettering Institute, has been named the recipient of two prestigious awards.

Thanks to pioneering work done at MSK, a powerful new form of radiation therapy is changing the treatment of advanced cancers.